Hewlett Packard

1 month ago | rcrwireless.com | Carrie Charles |technology. Carrie |Hewlett Packard |Eli Lilly attract

Innovation as a Service: Rethinking Digital Solutions with Yazz Krdzalic of Equus In this episode of Let’s Get Digital, Carrie Charles interviews Yazz Krdzalic, Vice President of Market Development at Equus Compute Solutions (ECS). Yazz shares how ECS is transforming digital infrastructure with immersion cooling systems that maximize compute power and private 5G networks enabling seamless connectivity in remote areas.

2 months ago | rcrwireless.com | Carrie Charles |technology. Carrie |Hewlett Packard |Eli Lilly attract

In this episode of Let’s Get Digital with Carrie Charles, we sit down with Dan Caruso, a powerhouse in telecommunications and digital infrastructure. Known as “The Bear” for his tenacity and drive, Dan is the visionary founder and former CEO of Zayo Group, where he led the company to a $14.3 billion exit. His unmatched track record includes co-founding Level 3 Communications, leadership at Metropolitan Fiber Systems (MFS), and now serving as the founder of Caruso Ventures.

2 months ago | emorybusiness.com | Áine Doris |Hewlett Packard

How can organizations make robust decisions when time is short, and the stakes are high? It’s a conundrum not unfamiliar to the U.S. Food and Drug Administration. Back in 2021, the FDA found itself under tremendous pressure to decide on the approval of the experimental drug aducanumab, designed to slow the progress of Alzheimer’s disease—a debilitating and incurable condition that ranks among the top 10 causes of death in the United States.

2 months ago | brnw.ch | Áine Doris |Hewlett Packard |Goizueta Effect

How can organizations make robust decisions when time is short, and the stakes are high? It’s a conundrum not unfamiliar to the U.S. Food and Drug Administration. Back in 2021, the FDA found itself under tremendous pressure to decide on the approval of the experimental drug aducanumab, designed to slow the progress of Alzheimer’s disease—a debilitating and incurable condition that ranks among the top 10 causes of death in the United States.

Dec 10, 2024 | ariva.de | Hewlett Packard

Dienstag, 10.12.2024 16:00 von Businesswire - Aufrufe: 38 Anaergia Inc. (“Anaergia”, the “Company”, “us”, or “our”) (TSX: ANRG), through its subsidiary, Anaergia Technologies, LLC (“Anaergia Technologies”), has expanded the scope of its activities with existing client Monterey One Water (“M1W”), in California, to operate an organic waste co-digestion facility at M1W’s Regional Treatment Plant (“RTP”).